IN8bio Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About IN8bio Inc
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.
/ 
Frequently asked questions
To buy IN8bio Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for IN8bio Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for IN8bio Inc is INAB:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
IN8bio Inc has its primary listing on NASDAQ. You can trade IN8bio Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, IN8bio Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include IN8bio Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like IN8bio Inc.